The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
Open accessAbstract
Angiogenesis is the growth of new capillaries from the preexisting blood vessels. Glioblastoma (GBM) tumors are highly vascularized tumors, and glioma growth depends on the formation of new blood vessels. Angiogenesis is a complex process involving proliferation, migration, and differentiation of vascular endothelial cells (ECs) under the stimulation of specific signals. It is controlled by the balance between its promoting and inhibiting factors. Various angiogenic factors and genes have been identified that stimulate glioma angiogenesis. Therefore, attention has been directed to anti-angiogenesis therapy in which glioma proliferation is inhibited by inhibiting the formation of new tumor vessels using angiogenesis inhibitory factors and drugs. Here, in this review, we highlight and summarize the various molecular mediators that regulate GBM angiogenesis with focus on recent clinical research on the potential of exploiting angiogenic pathways as a strategy in the treatment of GBM patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Chinot, O. L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A. F., Hoang-Xuan, K., Kavan, P., Cernea, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308345 · Cited by 2,557
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8721 · Cited by 2,466
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe'er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,043
Ostrom, Q. T., Gittleman, H., Liao, P., Vecchione-Koval, T., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox158 · Cited by 1,800
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Polymeric system for dual growth factor delivery
Richardson, T. P., Peters, M. C., Ennett, A. B., & Mooney, D. J. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1029 · Cited by 1,752
Dolecek, T. A., Propp, J. M., Stroup, N. E., & Kruchko, C. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos218 · Cited by 1,710
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Kreisl, T. N., Kim, L., Moore, K., Duic, P., Royce, C., Stroud, I., Garren, N., Mackey, M., Butman, J. A., Camphausen, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3055 · Cited by 1,577
Endothelial Cell Migration During Angiogenesis
Lamalice, L., Le Boeuf, F., & Huot, J. (2007) · Circulation Research · doi:10.1161/01.res.0000259593.07661.1e · Cited by 1,482
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Marcello, J., Reardon, D. A., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Sampson, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2440 · Cited by 1,394
Epidemiology and etiology of gliomas
Ohgaki, H., & Kleihues, P. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-0991-y · Cited by 1,252
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
The Definition of Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3002 · Cited by 1,132
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors
Goumans, M.-J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1743 · Cited by 1,123
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Dowell, J. M., Reardon, D. A., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Wagner, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2309 · Cited by 1,078
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Recent developments in the cell biology of basic fibroblast growth factor.
Rifkin, D. B., & Moscatelli, D. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.1 · Cited by 1,021
Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Semenza, G. L. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02090-1 · Cited by 930
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J. K., Fang, X., Sloan, A. E., Mao, Y., Lathia, J. D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.021 · Cited by 905
The PDGF family: four gene products form five dimeric isoforms
Fredriksson, L., Li, H., & Eriksson, U. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.007 · Cited by 838
Increased Vascularization in Mice Overexpressing Angiopoietin-1
Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., & Yancopoulos, G. D. (1998) · Science · doi:10.1126/science.282.5388.468 · Cited by 818
Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 812
Mechanisms of normal and tumor-derived angiogenesis
Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809
Taal, W., Oosterkamp, H. M., Walenkamp, A. M. E., Dubbink, H. J., Beerepoot, L. V., Hanse, M. C. J., Buter, J., Honkoop, A. H., Boerman, D., de Vos, F. Y. F., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70314-6 · Cited by 759
Targeting the tumour vasculature: insights from physiological angiogenesis
Chung, A. S., Lee, J., & Ferrara, N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2868 · Cited by 752
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
Trusolino, L., & Comoglio, P. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc779 · Cited by 745
Cao, R., Bråkenhielm, E., Pawliuk, R., Wariaro, D., Post, M. J., Wahlberg, E., Leboulch, P., & Cao, Y. (2003) · Nature Medicine · doi:10.1038/nm848 · Cited by 721
Hypoxia: A key regulator of angiogenesis in cancer
Liao, D., & Johnson, R. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9066-y · Cited by 721
TGF-β signaling by Smad proteins
Miyazono, K. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00025-8 · Cited by 626
Batchelor, T. T., Mulholland, P., Neyns, B., Nabors, L. B., Campone, M., Wick, A., Mason, W., Mikkelsen, T., Phuphanich, S., Ashby, L. S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.2464 · Cited by 614
Wick, W., Puduvalli, V. K., Chamberlain, M. C., van den Bent, M. J., Carpentier, A. F., Cher, L. M., Mason, W., Weller, M., Hong, S., Musib, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.2595 · Cited by 525
Batchelor, T. T., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Plotkin, S. R., Gerstner, E., Eichler, A. F., Drappatz, J., Hochberg, F. H., Benner, T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3988 · Cited by 520
de Groot, J. F., Fuller, G., Kumar, A. J., Piao, Y., Eterovic, K., Ji, Y., & Conrad, C. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop027 · Cited by 509
Combining two strategies to improve perfusion and drug delivery in solid tumors
Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508
Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., Israel, M. A., & Giese, N. A. (2002) · PubMed · Cited by 491
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Bruna, A., Darken, R. S., Rojo, F., Ocaña, A., Peñuelas, S., Arias, A., Paris, R., Tortosa, A., Mora, J., Baselga, J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.023 · Cited by 472
Stupp, R., Hegi, M. E., Neyns, B., Goldbrunner, R., Schlegel, U., Clement, P. M. J., Grabenbauer, G. G., Ochsenbein, A. F., Simon, M., Dietrich, P.-Y., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6650 · Cited by 454
TGF-β signaling by Smad proteins
Miyazono, K., Ten Dijke, P., & Heldin, C.-H. (2000) · Advances in Immunology · doi:10.1016/s0065-2776(00)75003-6 · Cited by 433
Heterogeneity of the Tumor Vasculature
Nagy, J., Chang, S.-H., Shih, S.-C., Dvorak, A., & Dvorak, H. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1253454 · Cited by 422
Ohgaki, H. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_14 · Cited by 418
Folkins, C., Shaked, Y., Man, S., Tang, T., Lee, C. R., Zhu, Z., Hoffman, R. M., & Kerbel, R. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0167 · Cited by 374
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
El Hallani, S., Boisselier, B., Peglion, F., Rousseau, A., Colin, C., Idbaih, A., Marie, Y., Mokhtari, K., Thomas, J. L., Eichmann, A., et al. (2010) · Brain · doi:10.1093/brain/awq044 · Cited by 374
Saksela, O., Moscatelli, D., & Rifkin, D. B. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.2.957 · Cited by 367
Signaling inputs converge on nuclear effectors in TGF-β signaling
ten Dijke, P., Miyazono, K., & Heldin, C.-H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01519-4 · Cited by 362
Senger, D. R., & Davis, G. E. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005090 · Cited by 349
Zhang, Y.-W., Su, Y., Volpert, O. V., & Woude, G. F. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135113100 · Cited by 348
Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis
Farin, A., Suzuki, S. O., Weiker, M., Goldman, J. E., Bruce, J. N., & Canoll, P. (2006) · Glia · doi:10.1002/glia.20334 · Cited by 343
Cheng, S. Y., Huang, H. J., Nagane, M., Ji, X. D., Wang, D., Shih, C. C., Arap, W., Huang, C. M., & Cavenee, W. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8502 · Cited by 342
Ferrari, G., Cook, B. D., Terushkin, V., Pintucci, G., & Mignatti, P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21706 · Cited by 340
Angiogenesis in malignant gliomas
Plate, K. H., & Risau, W. (1995) · Glia · doi:10.1002/glia.440150313 · Cited by 337
Biphasic Effect of Transforming Growth Factor-β1 on in Vitro Angiogenesis
Pepper, M. S., Vassalli, J.-D., Orci, L., & Montesano, R. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1043 · Cited by 329
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Franklin, R. A., Montalto, G., Cervello, M., Libra, M., Candido, S., Malaponte, G., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.659 · Cited by 314
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
Abounader, R., & Laterra, J. (2005) · Neuro-Oncology · doi:10.1215/s1152851705000050 · Cited by 300
Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis
Thurston, G. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0749-6 · Cited by 294
Zagzag, D., Amirnovin, R., Greco, M. A., Yee, H., Holash, J., Wiegand, S. J., Zabski, S., Yancopoulos, G. D., & Grumet, M. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780088 · Cited by 292
Gerwins, P., Sköldenberg, E., & Claesson-Welsh, L. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00062-7 · Cited by 290
Hermansson, M., Nistér, M., Betsholtz, C., Heldin, C., Westermark, B., & Funa, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7748 · Cited by 286
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
Pope, W. B., Lai, A., Nghiemphu, P., Mischel, P., & Cloughesy, T. F. (2006) · Neurology · doi:10.1212/01.wnl.0000208958.29600.87 · Cited by 271
佐本, 研. (1995) · Medical Entomology and Zoology · doi:10.11501/3108113 · Cited by 269
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
Chamberlain, M. C. (2006) · Neurology · doi:10.1212/01.wnl.0000250628.10420.d8 · Cited by 264
Novel anti-angiogenic therapies for malignant gliomas
Norden, A. D., Drappatz, J., & Wen, P. Y. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70260-6 · Cited by 246
Narayana, A., Kelly, P., Golfinos, J., Parker, E., Johnson, G., Knopp, E., Zagzag, D., Fischer, I., Raza, S., Medabalmi, P., et al. (2009) · Journal of Neurosurgery · doi:10.3171/2008.4.17492 · Cited by 243
Nabors, L. B., Fink, K. L., Mikkelsen, T., Grujicic, D., Tarnawski, R., Nam, D. H., Mazurkiewicz, M., Salacz, M., Ashby, L., Zagonel, V., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou356 · Cited by 242
de Groot, J. F., Lamborn, K. R., Chang, S. M., Gilbert, M. R., Cloughesy, T. F., Aldape, K., Yao, J., Jackson, E. F., Lieberman, F., Robins, H. I., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.1636 · Cited by 228
Iwamoto, F. M., Lamborn, K. R., Robins, H. I., Mehta, M. P., Chang, S. M., Butowski, N. A., DeAngelis, L. M., Abrey, L. E., Zhang, W.-T., Prados, M. D., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq025 · Cited by 223
The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades
Wang, M., Wang, T., Liu, S., Yoshida, D., & Teramoto, A. (2003) · Brain Tumor Pathology · doi:10.1007/bf02483449 · Cited by 219
Nicholas, M. K., Lukas, R. V., Jafri, N. F., Faoro, L., & Salgia, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0874 · Cited by 214
Vessel abnormalization: another hallmark of cancer?
De Bock, K., Cauwenberghs, S., & Carmeliet, P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.008 · Cited by 213
Hatva, E., Kaipainen, A., Mentula, P. J., Jääskeläinen, J. E., Paetau, A. E., Haltia, M., & Alitalo, K. K. (1995) · Europe PMC (PubMed Central) · Cited by 203
Herrlinger, U., Schäfer, N., Steinbach, J. P., Weyerbrock, A., Hau, P., Goldbrunner, R., Friedrich, F., Rohde, V., Ringel, F., Schlegel, U., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4691 · Cited by 201
Transforming growth factor‐β signaling in cancer invasion and metastasis
Leivonen, S., & Kähäri, V. (2007) · International Journal of Cancer · doi:10.1002/ijc.23113 · Cited by 191
Abou-Ghazal, M., Yang, D. S., Qiao, W., Reina-Ortiz, C., Wei, J., Kong, L.-Y., Fuller, G. N., Hiraoka, N., Priebe, W., Sawaya, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1329 · Cited by 191
Petrella, B. L., Lohi, J., & Brinckerhoff, C. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208305 · Cited by 188
Abounader, R., Lal, B., Luddy, C., Koe, G., Davidson, B., Rosen, E. M., & Laterra, J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0421fje · Cited by 186
Escuin, D., Kline, E. R., & Giannakakou, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4095 · Cited by 183
Scaling rules for diffusive drug delivery in tumor and normal tissues
Baish, J. W., Stylianopoulos, T., Lanning, R. M., Kamoun, W. S., Fukumura, D., Munn, L. L., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018154108 · Cited by 182
Lu-Emerson, C., Duda, D. G., Emblem, K. E., Taylor, J. W., Gerstner, E. R., Loeffler, J. S., Batchelor, T. T., & Jain, R. K. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9575 · Cited by 179
Takahashi, J. A., Fukumoto, M., Igarashi, K., Oda, Y., Kikuchi, H., & Hatanaka, M. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.5.0792 · Cited by 171
Oligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
Kim, K.-T., Choi, H.-H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H.-Z., Lee, G. M., & Koh, G. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500292200 · Cited by 170
Scholz, A., Harter, P. N., Cremer, S., Yalcin, B. H., Gurnik, S., Yamaji, M., Di Tacchio, M., Sommer, K., Baumgarten, P., Bähr, O., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505505 · Cited by 169
Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects
Batchelor, T. T., Reardon, D. A., de Groot, J., Wick, W., & Weller, M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0834 · Cited by 165
Li, X.-Y., Zhao, Y., Sun, M.-G., Shi, J.-F., Ju, R.-J., Zhang, C.-X., Li, X.-T., Zhao, W.-Y., Mu, L.-M., Zeng, F., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.049 · Cited by 163
Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
Zagzag, D., Miller, D. C., Sato, Y., Rifkin, D. B., & Burstein, D. (1990) · PubMed · Cited by 162
VEGF, a prosurvival factor, acts in concert with TGF-β1 to induce endothelial cell apoptosis
Ferrari, G., Pintucci, G., Seghezzi, G., Hyman, K., Galloway, A. C., & Mignatti, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605556103 · Cited by 160
Erythropoietin as an angiogenic factor
Ribatti, D., Vacca, A., Roccaro, A. M., Crivellato, E., & Presta, M. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01245.x · Cited by 160
Anti-angiogenic therapy for high-grade glioma
Ameratunga, M., Pavlakis, N., Wheeler, H., Grant, R., Simes, J., & Khasraw, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008218.pub4 · Cited by 159
Sa, G., Murugesan, G., Jaye, M., Ivashchenko, Y., & Fox, P. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2360 · Cited by 158
Molecular targeting of glioblastoma: Drug discovery and therapies
Bai, R.-Y., Staedtke, V., & Riggins, G. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.011 · Cited by 158
Kim, Y., Kim, E. H., Wu, Q., Guryanova, O. A., Hitomi, M., Lathia, J. D., Serwanski, D. R., Sloan, A. E., Weil, R. J., Lee, J., et al. (2012) · Genes & Development · doi:10.1101/gad.193565.112 · Cited by 153
Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation
Francescone, R., Scully, S. J., Bentley, B., Yan, W., Taylor, S. L., Oh, D. S., Moral, L. A., & Shao, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334540 · Cited by 148
Proteases and Glioma Angiogenesis
Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00118.x · Cited by 146
Self-citationMartinho, O., Longatto‐Filho, A., Lambros, M. B., Martins, A. M., Pinheiro, C. M., da Silva, A. S. L., Pardal, F., de Amorim, J. A., Mackay, A. G., Milanezi, F., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605225 · Cited by 146
Sengupta, S., Gherardi, E., Sellers, L. A., Wood, J. M., Sasisekharan, R., & Fan, T. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000048701.86621.d0 · Cited by 145
Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis
Sasaki, K., Murohara, T., Ikeda, H., Sugaya, T., Shimada, T., Shintani, S., & Imaizumi, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13055 · Cited by 144
Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases
Chantrain, C. F., Henriet, P., Jodele, S., Emonard, H., Féron, O., Courtoy, P. J., DeClerck, Y. A., & Marbaix, É. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.010 · Cited by 144
Reardon, D. A., Vredenburgh, J. J., Desjardins, A., Peters, K. B., Gururangan, S., Sampson, J. H., Marcello, J. E., Herndon, J. E., McLendon, R. E., Janney, D., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0217-6 · Cited by 138
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
Norden, A. D., Drappatz, J., Muzikansky, A., David, K., Gerard, M., McNamara, M. B., Phan, P., Ross, A., Kesari, S., & Wen, P. Y. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9745-8 · Cited by 137
PI3K and STAT3: A New Alliance
Vogt, P. K., & Hart, J. R. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0218 · Cited by 135
Recent Advances in Anti-Angiogenic Therapy of Cancer
Samant, R. S., & Shevde, L. A. (2011) · Oncotarget · doi:10.18632/oncotarget.234 · Cited by 134
Platten, M., Wick, W., Wild‐Bode, C., Aulwurm, S., DICHGANS, J., & Weller, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2176 · Cited by 133
Yao, X., Ping, Y., Liu, Y., Chen, K., Yoshimura, T., Liu, M., Gong, W., Chen, C., Niu, Q., Guo, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057188 · Cited by 132
Du, R., Petritsch, C. K., Lu, K. V., Liu, P., Haller, A., Ganß, R., Song, H., VandenBerg, S. R., & Bergers, G. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-001 · Cited by 132
Reardon, D. A., Groves, M. D., Wen, P. Y., Nabors, B., Mikkelsen, T., Rosenfeld, S., Raizer, J. J., Barriuso, J., McLendon, R. E., Suttle, A. B., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1707 · Cited by 132
New Directions in Anti-Angiogenic Therapy for Glioblastoma
Wang, N., Jain, R. K., & Batchelor, T. T. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0510-y · Cited by 129
Angiogenesis as a Therapeutic Target in Malignant Gliomas
Chi, A. S., Sorensen, A. G., Jain, R. K., & Batchelor, T. T. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0272 · Cited by 121
Choi, E. J., Cho, B. J., Lee, D., Hwang, Y., Chun, S. H., Kim, H. H., & Kim, I. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-17 · Cited by 117
Kanda, S., Landgren, E., Ljungström, M., & Claesson, L. (1996) · PubMed · Cited by 112
Renner, O., Tsimpas, A., Sawa Kostin, D., Valable, S., Petit, E., Schaper, W. K. A., & Marti, H. H. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00085-8 · Cited by 106
Continuous daily sunitinib for recurrent glioblastoma
Kreisl, T. N., Smith, P., Sul, J., Salgado, C., IWAMOTO, F. M., Shih, J. H., & Fine, H. A. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0988-z · Cited by 106
Xue, Q., Cao, L. H., Chen, X.-Y., Zhao, J., Gao, L., Li, S., & Fei, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.5567 · Cited by 106
Kuhnert, F., Tam, B. Y. Y., Sennino, B., Gray, J. T., Yuan, J., Jocson, A., Nayak, N. R., Mulligan, R. C., McDonald, D. M., & Kuo, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803194105 · Cited by 103
Minniti, G. C., Salvati, M., Arcella, A., Buttarelli, F. R., D’Elia, A., Lanzetta, G., Esposito, V., Scarpino, S., Enrici, R. M., & Giangaspero, F. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0324-4 · Cited by 101
A phase I/II trial of vandetanib for patients with recurrent malignant glioma
Kreisl, T. N., McNeill, K. A., Sul, J., Iwamoto, F. M., Shih, J. H., & Fine, H. A. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos265 · Cited by 96
Minder, P., Zając, E., Quigley, J. P., & Deryugina, E. I. (2015) · Neoplasia · doi:10.1016/j.neo.2015.08.002 · Cited by 95
Cantanhede, I. G., & de Oliveira, J. R. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-15045-w · Cited by 95
Reardon, D. A., Egorin, M. J., Desjardins, A., Vredenburgh, J. J., Beumer, J. H., Lagattuta, T. F., Gururangan, S., Herndon, J. E., Salvado, A. J., & Friedman, H. S. (2009) · Cancer · doi:10.1002/cncr.24213 · Cited by 91
de Groot, J., Liang, J., Kong, L.-Y., Wei, J., Piao, Y., Fuller, G. N., Qiao, W., & Heimberger, A. B. (2012) · Oncotarget · doi:10.18632/oncotarget.663 · Cited by 90
Stan, A. C., Nemati, M., Pietsch, T., Walter, G. F., & Dietz, H. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.82.6.1044 · Cited by 81
Antiangiogenic therapy in brain tumors
Lakka, S. S., & Rao, J. S. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.10.1457 · Cited by 80
Self-citationLee, O.-H., Xu, J., Fueyo-Margareto, J., Fuller, G. N., Aldape, K., Alonso, M. M., Piao, Y., Liu, T.-J., Lang, F. F., Bekele, B. N., et al. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0184 · Cited by 78
Siemann, D. W., Chaplin, D. J., & Horsman, M. R. (2017) · Cancer Investigation · doi:10.1080/07357907.2017.1364745 · Cited by 78
Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme
Muhic, A., Poulsen, H. S., Mau‐Sørensen, M., Grunnet, K., & Lassen, U. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1009-y · Cited by 75
Angiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis
Brunckhorst, M. K., Wang, H., Lu, R., & Yu, Q. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4125 · Cited by 75
TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy
van Meeteren, L. A., Goumans, M., & ten Dijke, P. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798808338 · Cited by 74
Molecular Therapeutic Targets for Glioma Angiogenesis
Takano, S., Yamashita, T., & Ohneda, O. (2010) · Journal of Oncology · doi:10.1155/2010/351908 · Cited by 74
Wick, W., Brandes, A. A., Gorlia, T., Bendszus, M., Sahm, F., Taal, W., TAPHOORN, M. J. B., Dômont, J., Idbaïh, A., Campone, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.2001 · Cited by 70
Krishnan, S., Szabó, E., Burghardt, I., Frei, K., Tabatabai, G., & Weller, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4310 · Cited by 69
Mao, J., Liu, J., Guo, G., Mao, X., & Li, C. (2015) · Biomarker Research · doi:10.1186/s40364-015-0034-3 · Cited by 69
HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration
Fitsialos, G., Bourget, I., Augier, S., Ginouvès, A., Rezzonico, R., Odorisio, T., Cianfarani, F., Virolle, T., Pouysségur, J., Meneguzzi, G., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.029256 · Cited by 65
Tabouret, É., Boudouresque, F., Barrié, M., Matta, M., Boucard, C., Loundou, A., Carpentier, A., Sanson, M., Métellus, P., Figarella‐Branger, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not226 · Cited by 65
Sun, X. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i17.2524 · Cited by 62
Angiopoietin-3 Inhibits Pulmonary Metastasis by Inhibiting Tumor Angiogenesis
Yin, X., Liu, Y., & Yu, Q. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1054 · Cited by 59
New radiotracers for imaging of vascular targets in angiogenesis-related diseases
Hong, H., Chen, F., Zhang, Y., & Cai, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.011 · Cited by 58
Keßler, T., Sahm, F., Blaes, J., Osswald, M., Rübmann, P., Milford, D., Urban, S., Jestaedt, L., Heiland, S., Bendszus, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2910 · Cited by 56
Huang, M., Ke, Y., Sun, X., Li, Y., Yang, Z., Zhang, Y., Du, M.-X., Wang, J., Liu, X., & Huang, S. (2014) · Oncology Reports · doi:10.3892/or.2014.3454 · Cited by 56
Lin, J.-L., Wang, M. J., Lee, D., Liang, C.-C., & Lin, S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.06.033 · Cited by 55
Yang, X., Chen, G.-L., Yu, S., Xu, C. S., Xin, Y.-H., Li, T., Shi, Y., Ai, G., Duan, J., Qian, C., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.12.002 · Cited by 53
Guarnaccia, L., Navone, S. E., Trombetta, E., Cordiglieri, C., Cherubini, A., Crisà, F. M., Rampini, P. M., Miozzo, M. R., Fontana, L., Caroli, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27116-7 · Cited by 51
Antiangiogenic therapy in malignant gliomas
Norden, A. D., Drappatz, J., & Wen, P. Y. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831186ba · Cited by 46
Gleave, M. E., Hsieh, J., Wu, H., Hong, S. J., Zhau, H. E., Guthrie, P. D., & Chung, L. W. K. (1993) · PubMed · Cited by 46
Zhong, J., Ali, A. N., Voloschin, A. D., Liu, Y., Curran, W. J., CROCKER, I. R., & Shu, H. G. (2014) · Cancer · doi:10.1002/cncr.29234 · Cited by 45
PHILLIPS, H., ARMANI, M., Stavrou, D., Ferrara, N., & Westphal, M. (1993) · International Journal of Oncology · doi:10.3892/ijo.2.6.913 · Cited by 43
FDA cancels approval for bevacizumab in advanced breast cancer
Tanne, J. H. (2011) · BMJ · doi:10.1136/bmj.d7684 · Cited by 43
Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
Onishi, M., Kurozumi, K., Ichikawa, T., & Date, I. (2013) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra2013-0200 · Cited by 38
Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma
Mao, X., Wang, C., Liu, D.-Y., Zhang, X., Wang, L., Yan, M., Zhang, W., Zhu, J., Li, Z., Mi, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10029 · Cited by 38
Cam, M., Charan, M., Welker, A. M., Dravid, P., Studebaker, A. W., Leonard, J. R., Pierson, C. R., Nakano, I., Beattie, C. E., Hwang, E. I., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz190 · Cited by 32
HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways
Kim, S.-H., Wang, D., Park, Y., Katoh, H., Margalit, O., Sheffer, M., Wu, H., Holla, V. R., Lee, J., & DuBois, R. N. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.028 · Cited by 31
VEGF isoforms as outcome biomarker for anti-angiogenic therapy in recurrent glioblastoma
D’Alessandris, Q. G., Martini, M., Cenci, T., Capo, G., Ricci‐Vitiani, L., Larocca, L. M., & Pallini, R. (2015) · Neurology · doi:10.1212/wnl.0000000000001543 · Cited by 27
Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma
Okuda, T., Tasaki, T., Nakata, S., Yamashita, K., YOSHIOKA, H., Izumoto, S., Kato, A., & Fujita, M. (2017) · Anticancer Research · doi:10.21873/anticanres.11767 · Cited by 24
Lee, O.-H., Xu, J., Fueyo-Margareto, J., Alonso, M. M., Liu, D., Martín, V., Jiang, H., Piao, Y., Liu, T. J., & Gomez‐Manzano, C. (2007) · Oncogene · doi:10.1038/sj.onc.1210731 · Cited by 22
Role of vincristine in the inhibition of angiogenesis in glioblastoma
Park, K.-J., Yu, M. O., Park, D., Park, J. Y., Chung, Y.-G., & Kang, S.-H. (2016) · Neurological Research · doi:10.1080/01616412.2016.1211231 · Cited by 20
Antiangiogenic Therapy of High-Grade Gliomas
Jo, J., & Wen, P. Y. (2018) · Progress in neurological surgery · doi:10.1159/000467379 · Cited by 18
Cited by
Glioblastoma at the crossroads: current understanding and future therapeutic horizons
Singh, S., Dey, D., Barik, D., Mohapatra, I., Kim, S., Sharma, M., Prasad, S., Wang, P., Singh, A., & Singh, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02299-4 · Cited by 287
Glioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
Frontiers in the treatment of glioblastoma: Past, present and emerging
Janjua, T. I., Rewatkar, P., Ahmed-Cox, A., Saeed, I., Mansfeld, F. M., Kulshreshtha, R., Kumeria, T., Ziegler, D. S., Kavallaris, M., Mazzieri, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.012 · Cited by 257
The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment
Hu, H., Chen, Y., Tan, S., Wu, S., Huang, Y., Fu, S., Luo, F., & He, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.802846 · Cited by 117
Astrocytes in the regulation of cerebrovascular functions
Cohen‐Salmon, M., Slaoui, L., Mazaré, N., Gilbert, A., Oudart, M., Alvear‐Perez, R., Elorza‐Vidal, X., Chever, O., & Boulay, A. (2021) · Glia · doi:10.1002/glia.23924 · Cited by 93
Metadata
- Authors
- Ahir, B. K., Engelhard, H. H., & Lakka, S. S.
- Venue
- Molecular Neurobiology
- Published
- 2020-03-09
- Volume
- 57
- Issue
- 5
- Pages
- 2461-2478
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W3009898868
- Cited by
- 424
- References
- 175
- FWCI
- 15.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.